Neutropenia is not required for clinical remission during azathioprine therapy in inflammatory bowel disease

European Journal of Gastroenterology and Hepatology

Volumn 13, Issue 9, 2001, Pages 1053-1055

  Persley, Kimberly M ^a   Present, Daniel H ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

6 mercaptopurine; Azathioprine; Inflammatory bowel disease; Neutropenia

Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE;

ALLERGIC REACTION; BONE MARROW SUPPRESSION; DRUG EFFECT; ENTERITIS; GENETIC SUSCEPTIBILITY; HUMAN; LEUKOCYTE COUNT; LEUKOPENIA; LIVER FUNCTION; LIVER TOXICITY; MONITORING; NAUSEA; NEUTROPENIA; PANCREATITIS; PRIORITY JOURNAL; REMISSION; SHORT SURVEY; ULCERATIVE COLITIS;

AZATHIOPRINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; LONG-TERM CARE; MALE; MONITORING, PHYSIOLOGIC; NEUTROPENIA; RECURRENCE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 0034802320     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/00042737-200109000-00009     Document Type: Article

References (11)

1. Feldman M, Scharschmidt B, Sleisenger MH (editors). Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. 6th ed. Philadelphia: WB Saunders; 1998.
2. Sandborn WJ. Azathioprine: state of the art in inflammatory bowel disease. Scand J Gastroenterol 1998; 33 (suppl 225): 92-99.
3. Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6-mercaptopurine in Crohn’s disease. A meta-analysis. Ann Int Med 1995; 123: 132-142.
4. Present DH, Meltzer SJ, Krumholz MP, Wolke A, Korelitz BI. 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. Ann Int Med 1989; 111: 641-649.
5. Kirschner BS. Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease. Gastroenterology 1998; 115: 813-821.
6. Dubinsky MA, Lamothe S, Yang HY, Targan SR, Sinnett D, Theoret Y, Seidman E. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology 2000; 118: 705-713.
7. Colonna T, Korelitz BI. The role of leukopenia in the 6-mercaptopurine-induced remission of refractory Crohn’s disease. Am J Gastroenterol 1994; 89: 362-366.
8. Campbell S, Ghosh S. Is neutropenia required for effective maintenance of remission during azathioprine therapy in inflammatory bowel disease? Eur J Gastroenterol Hepatol 2001; 13: 1073-1076.
9. Teachon K, Bjarnason I. Comparison of leukocyte excretion and blood loss in inflammatory disease of the bowel. Gut 1993; 34: 1535-1538.
10. Burke DA, Dixon MF, Axon ATR. Ulcerative colitis; prolonged remission following azathioprine-induced pancytopenia. J Clin Gastroenterol 1989; 11: 327-330.
11. Korelitz BI, Zlatanic J, Smith MJ, Lipe RJ, Baiocco PJ, Gleim GW. Significance of WBC differential when leukopenia is induced by 6-MP for IBD. Gastroenterology 1997; 113: 1810-1811.